Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-020726

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SKIBSTED RUSSELL Chief Financial Officer 2018-03-15 Grant or award · Option to Purchase Common Shares +150,000 150,000 D
Loading xslF345X03/doc4.xml…